A trial tested the efficacy of corticosteroids in reducing interstitial fibrosis after kidney transplantation in low-risk patients.

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...

A recent study led by Paul DeCaen, Ph.D., associate professor of Pharmacology, has identified novel molecular mechanisms by ...

A new research paper was published in Volume 16 of Oncotarget on June 25, 2025, titled "Hypoxia induced lipid droplet ...

Despite its profound impact on patient health, anemia of chronic kidney disease (CKD) remains underdiagnosed and undertreated.

Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...

This new article publication from Acta Pharmaceutica Sinica B, discusses high intensity forced ultrasound-driven ferroptosis ...

The human kidney is a masterclass in biological engineering. Responsible for filtering approximately 50 gallons of blood ...

Long-term exposure to water contaminants, even below the regulatory limits, significantly increases the risk of chronic ...

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...